Sanofi-aventis and the Juvenile Diabetes Research Foundation (JDRF) announced a unique partnership to develop therapeuti…
Research
Neurocrine Biosciences and Boehringer Ingelheim to Jointly Research and Develop Type 2 Diabetes Drug
Neurocrine Biosciences, Inc. announcedthat they have established a worldwide collaboration with Boehringer Ingelheim to …
Type 1 Diabetic Potential to Create Own Insulin
Researchers from the Peninsula Medical School, working in collaboration with colleagues from Glasgow Royal Infirmary and…
Type 1 Diabetes Associated With Viral Infection
Researchers at the University of Insubria in Varese, Italy, have found a significant link between type 1 diabetes and a …
Insulin Resistance Found in Healthy People After One Sleepless Night
The findings of a new study led by Esther Donga, MD of the Leiden University Medical Center in The Netherlands show a sh…
Stem Cell Treatment for Type 1 Diabetes Receives FDA Orphan Drug Designation
Osiris Therapeutics, Inc. announced that it has been granted Orphan Drug designation from the U.S. Food and Drug Adminis…
JDRF Funds Clinical Trial to Test Pig Islet Cells
The Juvenile Diabetes Research Foundation announced today that it is partnering with Living Cell Technologies (LCT), a N…
Fat Loss Boosts Immune System in Obese and Type 2 Diabetics
Scientists from the Garvan Institute of Medical Research in Sydney Australia have shown for the first time that even mod…
Gene May Tie Stress to Obesity and Diabetes
A research team led by Dr. Alon Chen of the Weizmann Institute’s Neurobiology Department has discovered that changes in …
Sanofi-Aventis and CureMD sign $335M Deal on Diabetes Cure Development
Sanofi-aventis announced that it has signed a global license agreement with CureDM Group on a novel human peptide, Pancr…
